Origin and transport of the AI and arginine-rich apolipoproteins in mesenteric lymph of rats.

K Imaizumi, RJ Havel, M Fainaru, JL Vigne - Journal of Lipid Research, 1978 - Elsevier
K Imaizumi, RJ Havel, M Fainaru, JL Vigne
Journal of Lipid Research, 1978Elsevier
Transport of apolipoprotein AI and argininerich apolipoprotein in mesenteric lymph was
examined in rats given constant intraduodenal infusions of saline, glucose in saline, or
emulsified fat. Lymph flow in all groups was constant from 5 to 50 hr after beginning the
infusions. Lymphatic transport of triglycerides was about 20-fold greater and transport of
apoprotein AI was about twofold greater in fat-infused rats than in the other two groups. In
each group transport of apoprotein AI bore a significant positive relationship to transport of …
Transport of apolipoprotein A-I and argininerich apolipoprotein in mesenteric lymph was examined in rats given constant intraduodenal infusions of saline, glucose in saline, or emulsified fat. Lymph flow in all groups was constant from 5 to 50 hr after beginning the infusions. Lymphatic transport of triglycerides was about 20-fold greater and transport of apoprotein A-I was about twofold greater in fat-infused rats than in the other two groups. In each group transport of apoprotein A-I bore a significant positive relationship to transport of triglycerides. Lymphatic transport of the arginine-rich apoprotein was only 6-12% of that of apoprotein A-I and was more closely related to lymphatic transport of total protein than to that of triglycerides. In fat-infused rats given [(3)H]lysine intraduodenally, about two-thirds of the (3)H in the chylomicron proteins was in apoprotein A-I and only about 1% was in the arginine-rich apoprotein. Estimated specific activity of chylomicron proteins was highest for apoprotein A-I and apoprotein A-IV, and lowest for the arginine-rich apoprotein and proteins of low molecular weight (mainly C apoproteins). In fat-infused rats given constant intravenous infusions of radioiodinated high density lipoproteins from blood plasma, the specific activity of apoprotein A-I in lymph chylomicrons was only about 5% of that of apoprotein A-I in blood high density lipoproteins, indicating that more than 90% of the apoprotein A-I in chylomicrons was synthesized in the intestine. From these and other data it is concluded that both the intestine and liver are significant sources of apoprotein A-I whereas only the liver synthesizes significant amounts of the arginine-rich apoprotein.
Elsevier